Effect of Lanqin Oral Liquid Combined with Recombinant Human Interferon α-2b Spray in the Treatment of Herpetic Angina
ZHANG Lei
TANG Yu
XU Shasha
CHEN Shouhang
Abstract：Objective To explore the effectiveness and safety of Lanqin oral liquid combined with recombinant human interferonα-2b in the treatment of heart and spleen heat accumulation syndrome in children with herpetic angina.Methods A random and controlled method was used to divide 120 children who met the standards and were treated at Henan Provincial Children's Hospital from January 2021 to December 2022 into a control group and a treatment group,with 60 cases in each group.The control group received recombinant human interferon α-2b spray(Pseudomonas),the treatment group received Lanqin oral liquid on the basis of the control group,with a course of 5 days.Clinical efficacy of two groups of pediatric patients,including fever relief time,pharyngeal pain disappearance time,herpes disappearance time,and total score of traditional Chinese medicine syndromes were evaluated,and the safety based on adverse drug reactions were evaluated.Results Compared with the control group,the treatment group could more effectively shorten the time for fever relief,pharyngeal pain disappearance,herpes disappearance,and improved traditional Chinese medicine syndromes in children with herpetic angina,and there were no serious adverse reactions during the treatment process.Conclusion The combination of Lanqin oral liquid and recombinant human interferon α-2b can improve the clinical efficacy of children with herpetic angina,which is superior to using recombinant human interferon α-2b alone,with good safety and worth adopting.
Keywords：herpetic anginaLanqin oral liquidrecombinant human interferontherapeutic effect
Publication Date：2025-01-14
Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)
Pages：4( 52-55 )